Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation
- PMID: 19283780
- DOI: 10.1002/eji.200838904
Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation
Abstract
The adoptive transfer of CD4(+)CD25(+) natural regulatory T cells (Treg) is a promising strategy for the treatment of autoimmune diseases and the prevention of alloresponses after transplantation. Clinical trials exploring this strategy require efficient in vitro expansion of this rare cell population. Protocols developed thus far rely on high-grade purification of Treg prior to culture initiation, a process still hampered by the lack of Treg cell-specific surface markers. Depletion of CD127(+) cells was shown to separate activated conventional T cells from natural Treg cell populations allowing the isolation of highly enriched FOXP3(+) cells with all functional and molecular characteristics of natural Treg. Here, we demonstrate that upon in vitro expansion, CpG methylation in a conserved region within the FOXP3 gene locus increased in CD4(+)CD25(+)CD127(low) Treg, correlating with loss of FOXP3 expression and emergence of pro-inflammatory cytokines. Further analysis identified CD45RA(-)FOXP3(+) memory-type Treg as the main source of converting cells, whereas CD45RA(+)FOXP3(+) Treg from the same donors showed no conversion within 3 wk of in vitro expansion. Thus, Treg cell lineage differentiation does not seem to represent a final fate decision, as natural Treg can lose their cell-type-specific characteristics after repetitive TCR stimulation.
Similar articles
-
Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.Exp Hematol. 2007 Mar;35(3):416-25. doi: 10.1016/j.exphem.2006.12.004. Exp Hematol. 2007. PMID: 17309822
-
Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.Eur J Immunol. 2008 May;38(5):1381-90. doi: 10.1002/eji.200737590. Eur J Immunol. 2008. PMID: 18412171
-
CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.Clin Immunol. 2009 Apr;131(1):109-18. doi: 10.1016/j.clim.2008.11.010. Epub 2009 Jan 18. Clin Immunol. 2009. PMID: 19153062
-
Expanding and converting regulatory T cells: a horizon for immunotherapy.Arch Immunol Ther Exp (Warsz). 2009 May-Jun;57(3):199-204. doi: 10.1007/s00005-009-0021-1. Epub 2009 May 29. Arch Immunol Ther Exp (Warsz). 2009. PMID: 19479206 Review.
-
Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells.Trends Immunol. 2006 Dec;27(12):541-4. doi: 10.1016/j.it.2006.10.002. Epub 2006 Oct 12. Trends Immunol. 2006. PMID: 17045841 Review.
Cited by
-
Cancer-Associated Fibroblasts: Accomplices in the Tumor Immune Evasion.Cancers (Basel). 2020 Oct 14;12(10):2969. doi: 10.3390/cancers12102969. Cancers (Basel). 2020. PMID: 33066357 Free PMC article. Review.
-
The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway.Front Immunol. 2012 Jul 5;3:190. doi: 10.3389/fimmu.2012.00190. eCollection 2012. Front Immunol. 2012. PMID: 22783261 Free PMC article.
-
T regulatory cells and the control of alloimmunity: from characterisation to clinical application.Curr Opin Immunol. 2010 Oct;22(5):662-8. doi: 10.1016/j.coi.2010.08.011. Epub 2010 Sep 23. Curr Opin Immunol. 2010. PMID: 20869224 Free PMC article. Review.
-
Advances in cellular therapy: 5th International Symposium on the clinical use of cellular products, 19 and 20 March 2009, Nürnberg, Germany.Cancer Immunol Immunother. 2010 Nov;59(11):1745-56. doi: 10.1007/s00262-009-0779-3. Epub 2009 Oct 28. Cancer Immunol Immunother. 2010. PMID: 19862524 Free PMC article. No abstract available.
-
Highly Purified Alloantigen-Specific Tregs From Healthy and Chronic Kidney Disease Patients Can Be Long-Term Expanded, Maintaining a Suppressive Phenotype and Function in the Presence of Inflammatory Cytokines.Front Immunol. 2021 Oct 28;12:686530. doi: 10.3389/fimmu.2021.686530. eCollection 2021. Front Immunol. 2021. PMID: 34777330 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous